Get Back to Sharing Special Moments
with Family and Friends
Find peace of mind with Flowflex!
- Easy-to-use nasal swab test
- Can be used to test children as young as 2 years old
- Results in 15 minutes
- No need to send off to a lab to obtain results
- Compact packaging for “On-The-Go” testing
Expiration Date Extension
All the Flowflex COVID-19 Antigen Home Test lot numbers eligible for the expiration date extension have expired. Please follow the expiration dates printed on the kit box and cassette pouch.
Please click here for the Flowflex COVID-19 Antigen Home Test (EUA210494)
Test Procedure Overview
This test procedure overview does not replace the package insert. Before you begin the test, it is important to read and follow the detailed instructions in the package insert.
Resources
Consumer Package Insert (English)
Consumer Package Insert (Spanish)
Healthcare Provider Package Insert
Quick Reference Instructions (English)
Quick Reference Instructions (Spanish)
Frequently Asked Questions
Where Can I Buy It?
For employee testing solutions, click here.
Need Support?
News
STATEMENT ON THE OMICRON BA.2 VARIANT
We at ACON Laboratories, Inc. have been continuously monitoring the emergence of COVID-19 variants. The Omicron variant (B.1.1.529) is currently the dominant variant circulating globally, accounting fornearly all sequences reported to GISAID. Omicron is made up of...
ACON Laboratories Issues a Recall of non-EUA Authorized “Flowflex™ SARS-CoV-2 Antigen Rapid Test (Self-Testing)” Tests From the U.S. Market
SAN DIEGO, CA, January 9, 2022 – ACON Laboratories, Inc. (“ACON Laboratories”), the legal manufacturer of the “Flowflex™ COVID-19 Antigen Home Test” (FDA Emergency Use Authorization EUA210494), has identified the U.S. distribution of unauthorized, adulterated and...
UPDATED STATEMENT ON THE OMICRON VARIANT
ACON Laboratories, Inc. has been continuously monitoring the emergence of SARS-CoV-2 variants, including the Omicron variant. We are pleased to report that an independent evaluation conducted by the National Institutes of Health’s (NIH) RADx program has indicated that...